Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has released an Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC). The update note ...
Investment analysts at Zacks Small Cap reduced their Q1 2025 EPS estimates for shares of Ensysce Biosciences in a research report issued to clients and investors on Tuesday, March 11th. Zacks Small ...
Alpha-1 is a genetic disease that impacts entire families for generations to come that is why the ladies say testing is so ...
Secures Strategic Partnership for the Development and Commercial Launch of PF614 and PF614-MPARGroundbreaking Trial on PF614-MPAR Generates Positive Interim Results SAN DIEGO, CA / ACCESS Newswire / M ...
A.N. Martin Systems has been working alongside farmers, providing reliable grain handling and storage solutions. Now, we’re bringing that same dedication to the dairy industry with the SoyRoaster ...
SAN DIEGO, CA / ACCESS Newswire / March 5, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for seve ...
Shah and colleagues take advantage of the presence of maternal and somatic ribosomes in zebrafish and confirm their differential expression during development. The authors convincingly show that ...
Viele Menschen reagieren auf Amylase-Trypsin-Inhibitoren, erklärt Professor Detlef Schuppan. Zusätzlich enthalten Brötchen häufig ungenannte Zusatzstoffe wie Phosphate, die die ...
This project has not set up a SECURITY.md file yet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback